Coagulation is initiated by tissue factor (TF). Coagulant TF is constitutively expressed by extravascular cells, but there is increasing evidence that TF can also be present within the blood, in particular during pathological conditions. Such TF is exposed on circulating cell-derived vesicles, and its presence has been associated with development of disseminated intravascular coagulation and venous thrombosis. For example, the presence of TF-exposing vesicles in the blood of cancer patients may be associated with their high risk of developing venous thromboembolism. Remarkably, high levels of coagulant TF-exposing vesicles are present in other body fluids such as saliva and urine of healthy persons, suggesting that these vesicles play a phy...
Abstract—Blood microparticles are vesicular structures with a diameter of 100 to 1000 nm that are pr...
Background: Because plasma of cancer patients presenting with venous thrombosis contains high number...
For many years, the attention on tissue factor (TF) in human pathophysiology has been limited to its...
AbstractCoagulation is initiated by tissue factor (TF). Coagulant TF is constitutively expressed by ...
AbstractCoagulation is initiated by tissue factor (TF). Coagulant TF is constitutively expressed by ...
© 2017 International Society on Thrombosis and Haemostasis Summary: Cancer is associated with an inc...
It is generally accepted that the initial event in coagulation and intravascular thrombus formation ...
© 2017 International Society on Thrombosis and Haemostasis Summary: Cancer is associated with an inc...
Tissue factor (TF) is present in blood in various forms, including small membrane vesicles called mi...
Tissue factor (TF) is present in blood in various forms, including small membrane vesicles called mi...
Background: Because plasma of cancer patients presenting with venous thrombosis contains high number...
Venous thromboembolism (VTE) is a leading cause of morbidity and mortality worldwide. However, the m...
Venous thromboembolism (VTE) is a leading cause of morbidity and mortality worldwide. However, the m...
Thrombotic events are the major complication in cancer patients, which contribute significantly to t...
Thrombotic events are the major complication in cancer patients, which contribute significantly to t...
Abstract—Blood microparticles are vesicular structures with a diameter of 100 to 1000 nm that are pr...
Background: Because plasma of cancer patients presenting with venous thrombosis contains high number...
For many years, the attention on tissue factor (TF) in human pathophysiology has been limited to its...
AbstractCoagulation is initiated by tissue factor (TF). Coagulant TF is constitutively expressed by ...
AbstractCoagulation is initiated by tissue factor (TF). Coagulant TF is constitutively expressed by ...
© 2017 International Society on Thrombosis and Haemostasis Summary: Cancer is associated with an inc...
It is generally accepted that the initial event in coagulation and intravascular thrombus formation ...
© 2017 International Society on Thrombosis and Haemostasis Summary: Cancer is associated with an inc...
Tissue factor (TF) is present in blood in various forms, including small membrane vesicles called mi...
Tissue factor (TF) is present in blood in various forms, including small membrane vesicles called mi...
Background: Because plasma of cancer patients presenting with venous thrombosis contains high number...
Venous thromboembolism (VTE) is a leading cause of morbidity and mortality worldwide. However, the m...
Venous thromboembolism (VTE) is a leading cause of morbidity and mortality worldwide. However, the m...
Thrombotic events are the major complication in cancer patients, which contribute significantly to t...
Thrombotic events are the major complication in cancer patients, which contribute significantly to t...
Abstract—Blood microparticles are vesicular structures with a diameter of 100 to 1000 nm that are pr...
Background: Because plasma of cancer patients presenting with venous thrombosis contains high number...
For many years, the attention on tissue factor (TF) in human pathophysiology has been limited to its...